Skip Navigation

European Heart Journal 1998 19(2):319-325; doi:10.1053/euhj.1997.0587
Copyright © 1998 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cunningham, D.A.
Right arrow Articles by Yacoub, M.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cunningham, D.A.
Right arrow Articles by Yacoub, M.H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Donor ACE gene polymorphism: a genetic risk factor for accelerated coronary sclerosis following cardiac transplantation

D.A. Cunningham, S.J. Crisp, M. Barbir, F. Lazem, M.J. Dunn and M.H. Yacoub

Division of Cardiothoracic Surgery, National Heart and Lung Institute, Imperial College of Science, Technology and Medicine, London, U.K.
Heart Science Centre, Harefield Hospital, Harefield, Middlesex, U.K.

accepted May 30, 1997

Aims

To investigate the role of angiotensin converting enzyme (ACE) (I/D) gene polymorphism in the development of coronary sclerosis after cardiac transplantation.

Methods and results

Eighty cardiac transplant recipients (44 transplant associated coronary artery disease; 36 non-transplant associated coronary artery disease) and their donors were genotyped by polymerase chain reaction. The allele frequencies of the recipients in the transplant associated coronary artery disease and non-transplant associated coronary artery disease groups (I=0·47 and 0·48, D=0·53 and 0·52, respectively) did not differ significantly between the groups. However, there was a negative association between the frequency of the I allele in the donor and the development of transplant associated coronary artery disease. The D allele in the donor population of the non-transplant associated coronary artery disease group had a significantly (P<0·01) lower frequency (0·35) than either the transplant associated coronary artery disease group (0·53) or that of the general population (0·57). Other factors analysed were recipient family history, cholesterol levels, age, sex and body mass index, donor age and acute rejection, of which the significant (P<0·05) factors were acute rejection and sex of the recipient.

Conclusion

These results suggest that the ACE genotype of the donor organ may be an additional risk factor for the development of coronary artery disease following cardiac transplantation and that tissue rather than circulating ACE could be implicated in the pathogenesis of this disease.

Key Words: Angiotensin • genes • arteriosclerosis • transplantation

Correspondence: Professor Magdi H. Yacoub, Department of Cardiothoracic Surgery, National Heart and Lung Institute, Heart Science Centre, Harefield Hospital, Harefield, Middlesex UB9 6JH, U.K.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
S. R. Auerbach, C. Manlhiot, S. Reddy, C. Kinnear, M. E. Richmond, D. Gruber, B. W. McCrindle, L. Deng, J. M. Chen, L. J. Addonizio, et al.
Recipient Genotype Is a Predictor of Allograft Cytokine Expression and Outcomes After Pediatric Cardiac Transplantation
J. Am. Coll. Cardiol., May 19, 2009; 53(20): 1909 - 1917.
[Abstract] [Full Text] [PDF]

Home page
 SEMIN CARDIOTHORAC VASC ANESTHHome page
A. A. Fox and N. A. Nussmeier
Does Gender Influence the Likelihood or Types of Complications Following Cardiac Surgery?
Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2004; 8(4): 283 - 295.
[Abstract] [PDF]

Home page
 SEMIN CARDIOTHORAC VASC ANESTHHome page
A. A. Fox, S. K. Shernan, and S. C. Body
Predictive Genomics of Adverse Events After Cardiac Surgery
Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2004; 8(4): 297 - 315.
[Abstract] [PDF]

Home page
 J Am Coll CardiolHome page
M. Yousufuddin, D. J. Cook, R. C. Starling, A. Abdo, P. Paul, E. M. Tuzcu, N. B. Ratliff, P. M. McCarthy, J. B. Young, and M. H. Yamani
Angiotensin II receptors from peritransplantation through first-year post-transplantation and the risk of transplant coronary artery disease
J. Am. Coll. Cardiol., May 5, 2004; 43(9): 1565 - 1573.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
M. Yousufuddin, S. Haji, R. C. Starling, E. M. Tuzcu, N. B. Ratliff, D. J. Cook, A. Abdo, Y. Saad, S. S. Karnik, D. Wang, et al.
Cardiac angiotensin II receptors as predictors of transplant coronary artery disease following heart transplantation
Eur. Heart J., March 1, 2004; 25(5): 377 - 385.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
M. Pfohl, M. Koch, S. Prescod, K.K. Haase, H.U. Haring, and K.R. Karsch
Angiotensin I-converting enzyme gene polymorphism, coronary artery disease and myocardial infarction. An angiographically controlled study
Eur. Heart J., September 2, 1999; 20(18): 1318 - 1325.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.